Results 51 to 60 of about 66,532,360 (170)

¿De qué hablamos cuando hablamos de Costo de Oportunidad? [PDF]

open access: yes, 2020
As its title expresses, the work aims to reflect on some controversial aspects regarding the concept of «opportunity cost» applied in the management of organizations.
Cartier, Enrique Nicolás
core  

Costos [PDF]

open access: yes, 2022
La asignatura tiene como objetivo el conocimiento de la teoría general del costo y su aplicación a los casos concretos de costeo, la exposición de costos y resultados en los distintos tipos de organizaciones, ya sea industrial, comercial o de servicio ...
Departamento de Economía y Administración, Área Contabilidad
core   +1 more source

Cost–benefit analysis of first‐trimester pre‐eclampsia screening: comparison of multivariable Gaussian algorithm with and without placental growth factor

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 2, Page 162-167, February 2026.
ABSTRACT Objective Pre‐eclampsia (PE) is a leading cause of maternal and neonatal morbidity and mortality worldwide. Early identification of high‐risk pregnancies in the first trimester allows preventive treatment with low‐dose aspirin. This study aimed to evaluate whether multivariable Gaussian algorithm‐based PE screening strategies, with and without
E. Bonacina   +10 more
wiley   +1 more source

El “enfoque agronómico” de costos en empresas agropecuarias [PDF]

open access: yes, 2020
Las empresas agropecuarias pueden definirse como unidades de organización que producen bienes -agrícolas y/o pecuarios- a través de la gestión de “procesos productivos biológicos”.En general, los productos de la empresa agropecuaria son colocados en los “
Cartier, Enrique Nicolás
core  

Costos y precios de importación y exportación [PDF]

open access: yes, 2023
Fil: Ruschanoff, Hugo. Universidad Nacional de Quilmes. Departamento de Economía y Administración; ArgentinaFil: Ruschanoff, Fabián. Universidad Nacional de Quilmes.
Ruschanoff, Fabián, Ruschanoff, Hugo
core   +1 more source

Examining the Perspectives of Key Stakeholders on the Problems, Policies, and Politics Regarding Accessing Psychedelic Interventions to Alleviate End‐of‐Life Distress

open access: yesPolitics &Policy, Volume 54, Issue 1, February 2026.
ABSTRACT Psychedelic interventions are not publicly available through Canada's healthcare system. Despite growing scientific evidence, public interest, and efforts to expand access to psychedelic therapies for end‐of‐life psychological suffering, Canadian policies remain restrictive.
Sarah Kratina   +4 more
wiley   +1 more source

Control de costos y análisis de valor ganado

open access: yes, 2018
Se describe el proceso de control de costos que monitorea la situación del proyecto y actualiza la línea base de costo.
Guerrero Chanduví, Dante A.
core   +1 more source

Study of implementation and direct cost estimates for diagnostic tests for human visceral leishmaniasis in an urban area in Brazil

open access: yesCadernos de Saúde Pública, 2015
This work reports the process and costs of comprehensively implementing two tests to decentralize the diagnosis of visceral leishmaniasis (VL) in an endemic city in Brazil: a rapid test (IT LEISH) and a direct agglutination test (DAT-LPC).
Tália Santana Machado de Assis   +5 more
doaj   +1 more source

Comparison of drone and ground surveys for the detection of a rare plant in a fragile ecosystem

open access: yesEcological Solutions and Evidence, Volume 7, Issue 1, January–March 2026.
We compared the accuracy, time, and financial costs of drone and ground surveys for the detection of wood lilies (Lilium philadelphicum) in an endangered alvar ecosystem. We found that the drone surveys detected 73%–78% of the plants found in the ground surveys, but that this type of survey was more expensive and time consuming than the ground survey ...
Ana Hernández Martínez de la Riva   +3 more
wiley   +1 more source

Costo-efectividad incremental del palivizumab en prematuros en la Seguridad Social de Costa Rica. 2010-2017

open access: yesHorizonte Sanitario, 2020
Objetivo: Estimar la eficiencia mediante el análisis costo-efectividad incremental de la terapia con Palivizumab contra la práctica clínicahabitual en el período 2010-2017.Materiales y Métodos:Se realizó una evaluación económica completa del tipo costo ...
Luis Guillermo Jiménez Herrera   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy